Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €10.88 | €27.80 | 155.551% |
| Zoetis Inc. A | 23 | 1 | 4 | 0 | €158.72 | €200.06 | 26.044% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 4 | 0 | €547.90 | €568.09 | 3.686% |
| CONMED Corp. | 12 | 1 | 4 | 0 | €69.00 | €106.18 | 53.883% |
| AbbVie Inc. | 22 | 0 | 4 | 0 | €152.46 | €175.11 | 14.857% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €69.00 | €84.52 | 22.494% |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | €55.00 | €85.64 | 55.715% |
| Heron Therapeutics Inc. | 11 | 1 | 4 | 0 | €3.12 | €4.59 | 47.083% |
| MacroGenics Inc. | 12 | 0 | 4 | 0 | €4.02 | €12.99 | 223.506% |
| Merit Medical Systems | 17 | 0 | 4 | 0 | €74.50 | €86.90 | 16.640% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €288.40 | €297.31 | 3.090% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 4 | 0 | €60.50 | €79.55 | 31.495% |
| Gilead Sciences Inc | 11 | 1 | 5 | 0 | €62.28 | €84.81 | 36.179% |
| Tenet Healthcare | 28 | 0 | 5 | 0 | €119.00 | €124.47 | 4.600% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 5 | 0 | €903.00 | €958.32 | 6.126% |
| HCA Holdings Inc. | 23 | 0 | 5 | 0 | €296.90 | €303.80 | 2.323% |
| Stryker Corp. | 23 | 0 | 6 | 0 | €304.90 | €335.03 | 9.882% |
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | €719.70 | €771.54 | 7.203% |
| Insmed Inc. | 18 | 1 | 6 | 1 | €22.80 | €44.16 | 93.705% |
| Biogen Inc. | 47 | 1 | 7 | 1 | €211.60 | €294.45 | 39.153% |
| Vertex Pharmaceuticals Inc. | 46 | 2 | 7 | 0 | €411.55 | €409.07 | -0.603% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €129.05 | €140.60 | 8.953% |
| Boston Scientific | 47 | 0 | 10 | 0 | €69.00 | €73.22 | 6.120% |